NCT02526966View on ClinicalTrials.gov

Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
IgA Nephropathy
Interventions
BIOLOGICAL

blood sample

dosage of anti-hinge region antibodies

Trial Locations (15)

21000

CHU de DIJON, Dijon

26000

CH de VALENCE, Valence

26100

Hôpitaux Drome Nord, Romans

38000

CHU de GRENOBLE, Grenoble

42000

CHU de SAINT-ETIENNE, Saint-Etienne

42300

CH de ROANNE, Roanne

43000

CH du PUY EN VELAY, Le Puy-en-Velay

63000

CHU de CLERMONT-FERRAND, Clermont-Ferrand

69003

Hôpital Edouard. HERRIOT, Lyon

69100

Clinique du TONKIN, Villeurbanne

69310

Centre Hospitalier de Lyon Sud, Pierre-Bénite

73000

CH de CHAMBERY, Chambéry

74000

CH d'ANNECY, Annecy

07100

CH d'ANNONAY, Annonay

01000

CH de BOURG EN BRESSE, Bourg-en-Bresse

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT02526966 - Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy | Biotech Hunter | Biotech Hunter